Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAMPT | P43490 | 6/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | HTR1A | P08908 | 1/20 | 0.46 |
| ▸ | DRD2 | P14416 | 1/20 | 0.46 |
| ▸ | NAPRT | Q6XQN6 | 2/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | CA9 | Q16790 | 1/20 | 0.43 |
| ▸ | LTA4H | P09960 | 1/20 | 0.42 |
| ▸ | PDE4A | P27815 | 1/20 | 0.42 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.42 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.42 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28268031 | 0.90 | KMT2A (0.48) | NAMPTKMT2AMAPK1RAB9AKDM4E | |
| SCHEMBL8075924 | 0.86 | PKM (0.49) | NAMPTKMT2AKDM4ELMNACYP2C9 | |
| SCHEMBL30612269 | 0.86 | PKM (0.49) | NAMPTKMT2AKDM4ELMNACYP2C9 | |
| SCHEMBL28017528 | 0.84 | NAMPT (0.48) | NAMPTKMT2AMAPK1RAB9AKDM4E | |
| SCHEMBL776677 | 0.82 | CA2 (0.61) | TDP1CA1CA2CA9 | |
| SCHEMBL4514995 | 0.81 | LMNA (0.51) | NAMPTKMT2ATDP1LMNACYP2C9 | |
| SCHEMBL7286478 | 0.81 | CA2 (0.59) | TDP1CA1CA2CA9 | |
| SCHEMBL11414929 | 0.79 | CA2 (0.55) | KMT2AKDM4ETDP1CA1CA2 | |
| SCHEMBL28923713 | 0.78 | NAPRT (0.49) | NAMPTKMT2ANAPRTTDP1LMNA | |
| SCHEMBL556847 | 0.78 | CHRNB2 (0.46) | NAMPTNAPRTTDP1PDE4APDE4B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7612097-B2 | Method for producing bactericidal pyridine compound and bactericidal pyridine compound | TAMA KAGAKU KOGYO CO., LTD. (JP) | 2009-11-03 | — | — | US | disclosed |
| US-20070099961-A1 | Method for producing bactericidal pyridine compound and bactericidal pyridine compound | Kourai, Hiroki (JP) | 2007-05-03 | — | — | US | disclosed |
| EP-1683787-A1 | METHOD FOR PRODUCING BACTERICIDAL PYRIDINE COMPOUND AND BACTERICIDAL PYRIDINE COMPOUND | Tama Kagaku Kogyo Co., Ltd. (JP) | 2006-07-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070099961-A1 | Method for producing bactericidal pyridine compound and bactericidal pyridine compound | BLVRB, CBR3, TLR7 | NAMPT 1935/4885KMT2A 4004/4885MAPK1 291/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.